On January 31, 2020, HHS declared a public health emergency (Declaration) pursuant to the
Public Readiness and Emergency Preparedness Act (PREP Act), in response to the COVID–
19 outbreak.
The Substance Abuse and Mental Health Services Administration (SAMHSA) and the Drug
Enforcement Administration (DEA) are issuing this temporary rule to extend certain exceptions
granted to existing DEA regulations in March 2020 because of the COVID-19 Public Health
Emergency (COVID-19 PHE).
AMCP's volunteers are vital players in propelling our mission forward. In this installment of the AMCP Volunteer Spotlight, we are featuring Matt Moen, PharmD, MBA, AMCP Membership Committee member.
Health care expert Fred Goldstein, host of the AMCP Podcast Series — Listen Up! sits down with Melissa Andel, Principal and Founder of CommonHealth Solutions to take a closer look at the recent CMS guidance on drug price negotiation for 2026.
Health care expert Fred Goldstein, host of the AMCP Podcast Series — Listen Up! sits down with Melissa Andel, Principal and Founder of CommonHealth Solutions to take a closer look at the recent CMS guidance on drug price negotiation for 2026.
On April 5, 2023, the Centers for Medicare and Medicaid Services (CMS) issued a Final Rule,
titled “Medicare Program; Contract Year 2024 Policy and Technical Changes to the Medicare
Advantage Program, Medicare Prescription Drug Benefit Program, Medicare Cost Plan
Program, and Programs of All-Inclusive Care for the Elderly” (Final Rule).